Skip to main content
Fig. 4 | Clinical Proteomics

Fig. 4

From: Discovery of novel glioma serum biomarkers by proximity extension assay

Fig. 4

Combination of GFAP and FABP4 for discriminating gliomas (red circles) from meningiomas (blue dots) Anaplastic astrocytomas (red crossed diamonds) and anaplastic oligodendrogliomas (red double diamonds) are also shown. A: The vertical dashed line shows GFAP cut-ff at 100% specificity for gliomas and the horizontal dashed line shows FABP4 cut-off at 100% specificity for meningiomas. This model also aggregates the glioma cases by sub-type with glioblastomas having high GFAP, meningioma having low GFAP and high FABP4, while anaplastic astrocytomas and oligodendrogliomas display both low FABP4 and low GFAP [9, 10]. At 100% specificity (correct prediction of all 20 meningiomas) the sensitivity (correct prediction of gliomas) was 25/30 or 83%. B: Classification using logistic regression. We correctly classified 18/20 meningiomas (specificity of 90%) and 28/30 gliomas (sensitivity of 93%). The misclassified cases (two gliomas and two meningiomas) are circled

Back to article page